Ascendis Pharma A/S (ASND) vs Insmed, Inc. (INSM)

• Ascendis Pharma A/S ASND 225.78 ▼ −0.37%
• Insmed, Inc. INSM 96.27 ▼ −2.96%

Ascendis Pharma A/S and Insmed, Inc. are both Biotechnology companies. Insmed, Inc. is the larger, with a market value of $21.7B against $14.9B — 1.5× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Ascendis Pharma A/S trades at 16.3×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 126.0%. Ascendis Pharma A/S has the higher net margin (71.2% vs −76.9%) and the higher return on invested capital (15.1% vs −329.2%). Across the 18 metrics below, Ascendis Pharma A/S leads on 16 and Insmed, Inc. on 2.